Table 1.
Demographic and clinical characteristics of patients (N = 118).
| Clinical characteristics | N (%) |
| Male sex | 52 (44) |
| Age (yr); median (IQR) | 1.7 (1.1–2.8) |
| Underlying diseases | |
| Biliary atresia | 93 (78.8) |
| Acute liver failure | 7 (5.9) |
| Allagile syndrome | 4 (3.4) |
| Other causes of cirrhosis | 14 (11.8) |
| PELD score; median (IQR) | 19 (16–23) |
| Previous abdominal surgery before LT | 62 (52.5) |
| Donor | |
| Living Donor | 113 (95.8) |
| Cadaveric Donor | 5 (4.2) |
| Antibiotic exposure within 3 mo before LT | 63 (53.4) |
| Operation time (h); median (IQR) | 11.1 (10.1–12.5) |
| Cold ischemic time (min); median (IQR) | 72 (52–92) |
| Intraoperative complications | |
| Massive bleeding∗ | 84 (84) |
| Bowel injury | 6 (6) |
| Adrenal gland injury | 3 (3) |
| Vascular injury | 5 (5) |
| Biliary injury | 2 (2) |
| Hospital stay; median (IQR) | 48 (34–65) |
| <1 mo | 20 |
| 1–3 mo | 80 |
| >3 mo | 18 |
| Length of ICU stay (d); median (IQR) | 8 (6–14) |
| Duration of endotracheal intubation (d); median (IQR) | 3 (2–7) |
| Duration of urinary catheter (d); median (IQR) | 5 (3–6) |
| Duration of central venous catheter (d); median (IQR) | 12 (8–17) |
| Duration of abdominal drain (d); median (IQR) | 27 (20–37) |
| Early postoperative complications | |
| Bile leak | 27 (33) |
| Hepatic artery stenosis/thrombosis | 18 (21.9) |
| Hepatic vein stenosis/thrombosis | 18 (21.9) |
| Portal vein stenosis/thrombosis | 19 (23.2) |
| Sites of infection | |
| Intra-abdominal infection | 46 (46.4) |
| Bloodstream infection | 23 (23.2) |
| Urinary tract infection | 11 (11.1) |
| Pneumonia | 16 (16.2) |
| CMV reactivation | 37 (31.4) |
| EBV reactivation | 5 (4.2) |
| Acute graft rejection | 21 (17.8) |
| Postoperative surgical intervention (ie, liver biopsy, abdominal drain insertion, PTBD insertion, dilate hepatic vein) | 35 (29.6) |
| Re-operation | 58 (49.1) |
| Death | 8 (6.7) |